SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001144204-16-137923
Filing Date
2016-12-05
Accepted
2016-12-05 16:45:18
Documents
1
Period of Report
2016-12-05

Document Format Files

Seq Description Document Type Size
1 PREM14A v453799_prem14a.htm PREM14A 2172691
  Complete submission text file 0001144204-16-137923.txt   2173822
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-35076 | Film No.: 162034270
SIC: 2835 In Vitro & In Vivo Diagnostic Substances